XML 86 R35.htm IDEA: XBRL DOCUMENT v3.22.4

Alcon subsidiaries

12 Months Ended

Dec. 31, 2022

Disclosure Of Separate Financial Statements [Abstract]

Alcon subsidiaries

Alcon subsidiaries

The following table lists the subsidiaries of Alcon Inc. with Total assets or Net sales to third parties in excess of $5 million included in the Consolidated Financial Statements at and for the year ended December 31, 2022, respectively. The equity interest percentage shown in the table represents Alcon's share in voting rights in those entities. Unless otherwise stated, each entity has share capital consisting of equity held directly by the Company or another of its consolidated subsidiaries.

Country of organization/Entity name			Place of business			Equity interest
Argentina
Alcon Laboratorios Argentina S.A.			Buenos Aires			100		%
Australia
Alcon Laboratories (Australia) Pty Ltd			Macquarie Park			100		%
Austria
Alcon Ophthalmika GmbH			Wien			100		%
Belgium
Alcon Laboratories Belgium BVBA			Puurs			100		%
Alcon N.V.			Vilvoorde			100		%
Brazil
Alcon Brasil Cuidados com a Saúde Ltda.			São Paulo			100		%
Canada
Alcon Canada Inc.			Mississauga, Ontario			100		%
Chile
Alcon Laboratorios Chile Ltd.			Santiago de Chile			100		%
China
Alcon (China) Ophthalmic Product Co., Ltd.			Beijing			100		%
Alcon Hong Kong Limited			Hong Kong			100		%
Colombia
Laboratorios Alcon de Colombia S.A.			Santafé de Bogotá			100		%
Czech Republic
Alcon Pharmaceuticals (Czech Republic) s.r.o.			Prague			100		%
Denmark
Alcon Nordic A/S			Copenhagen			100		%
Ecuador
AlconLab Ecuador S.A.			Quito			100		%
France
Laboratoires Alcon S.A.S.			Rueil-Malmaison			100		%
Germany
Alcon Deutschland GmbH			Freiburg im Breisgau			100		%
CIBA Vision GmbH			Grosswallstadt			100		%
WaveLight GmbH			Erlangen			100		%
Greece
Alcon Laboratories Hellas- Single Member Commercial and Industrial S.A.C.I.			Maroussi, Athens			100		%
Hungary
Alcon Hungary Pharmaceuticals Trading Limited Liability Company			Budapest			100		%
India
Alcon Laboratories (India) Private Limited			Bangalore			100		%
Indonesia
PT. CIBA Vision Batam			Batam			100		%
Ireland
Alcon Laboratories Ireland Limited			Cork City			100		%
Aerie Pharmaceuticals Ireland Limited			Athlone			100		%
Israel
Optonol Ltd.			Neve-Ilan			100		%
Italy
Alcon Italia S.p.A.			Milano			100		%
Japan
Alcon Japan Ltd.			Tokyo			100		%

Country of organization/Entity name			Place of business			Equity interest
Malaysia
Alcon Laboratories (Malaysia) Sdn. Bhd.			Petaling Jaya			100		%
CIBA Vision Johor Sdn. Bhd.			Johor			100		%
Mexico
Alcon Laboratorios, S.A. de C.V.			Ciudad de Mexico			100		%
Netherlands
Alcon Finance B.V.			Amsterdam			100		%
Alcon Nederland B.V.			Gorinchem			100		%
New Zealand
Alcon Laboratories (New Zealand) Ltd.			Remuera			100		%
Panama
Alcon Centroamerica S.A.			Panama City			100		%
Peru
Alcon Pharmaceutical del Peru S.A.			Lima			100		%
Philippines
Alcon Laboratories (Philippines), Inc.			Pasig City			100		%
Poland
Alcon Polska Sp. z o.o.			Warszawa			100		%
Portugal
Alcon Portugal-Produtos e Equipamentos Oftalmológicos Lda.			Porto Salvo			100		%
Puerto Rico
Alcon (Puerto Rico), Inc.			Cataño, PR			100		%
Romania
Alcon Romania S.R.L.			Bucharest			100		%
Russian Federation
Alcon Farmacevtika LLC			Moscow			100		%
Singapore
Alcon Pte Ltd			Singapore			100		%
Alcon Singapore Manufacturing Pte Ltd			Singapore			100		%
CIBA Vision Asian Manufacturing and Logistics Pte Ltd.			Singapore			100		%
South Africa
Alcon Laboratories (South Africa) (Pty) Ltd.			Midrand			100		%
South Korea
Alcon Korea Ltd.			Seoul			100		%
Spain
Alcon Healthcare S.A.			Barcelona			100		%
Switzerland
Alcon Grieshaber AG			Schaffhausen			100		%
Alcon Management SA			Vernier			100		%
Alcon Pharmaceuticals Ltd.			Fribourg			100		%
Alcon Services AG			Fribourg			100		%
Alcon Switzerland SA			Zug			100		%
Thailand
Alcon Laboratories (Thailand) Limited			Bangkok			100		%
Turkey
Alcon Laboratuvarlari Ticaret A.S.			Istanbul			100		%
Ukraine
Alcon Ukraine LLC			Kiev			100		%

Country of organization/Entity name			Place of business			Equity interest
United Kingdom
Alcon Eye Care UK Limited			Frimley/Camberley			100		%
United States of America
Aerie Distribution, Inc.			Fort Worth, TX			100		%
Aerie Pharmaceuticals, Inc.			Fort Worth, TX			100		%
Alcon Finance Corporation			Fort Worth, TX			100		%
Alcon Laboratories, Inc.			Fort Worth, TX			100		%
Alcon RefractiveHorizons, LLC			Fort Worth, TX			100		%
Alcon Research, LLC			Fort Worth, TX			100		%
Alcon Vision, LLC			Fort Worth, TX			100		%
CIBA Vision, LLC			Fort Worth, TX			100		%
WaveLight, Inc.			Fort Worth, TX			100		%
Ivantis, Inc.			Fort Worth, TX			100		%
MDBackline, Inc.			Fort Worth, TX			100		%
PowerVision, Inc.			Fort Worth, TX			100		%
Tear Film Innovations, Inc.			Fort Worth, TX			100		%
TrueVision Systems, Inc.			Fort Worth, TX			100		%
Uruguay
Alcon Laboratorios Uruguay S.A.			Montevideo			100		%

X

- Definition

Disclosure Of Separate Financial Statements [Abstract]

+ References

No definition available.

+ Details

Name:	alc_DisclosureOfSeparateFinancialStatementsAbstract
Namespace Prefix:	alc_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of subsidiaries. [Refer: Subsidiaries [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2022-03-24
-Paragraph 17
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b&doctype=Standard
-URIDate 2022-03-24

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2022-03-24
-Paragraph 16
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b&doctype=Standard
-URIDate 2022-03-24

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2022-03-24
-Paragraph B4
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration